Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-68,961
Closed -$1.01M 63
2025
Q3
$1.01M Buy
+68,961
New +$703K 0.62% 44

Other funds holding ETNB

Monimus Capital Management's ETNB Position: Q4 2025 in Review

Monimus Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 68,961 shares — an estimated $1.01M sold.

Monimus Capital Management first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $1.01M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Monimus Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Monimus Capital Management sold 68,961 89bio shares in Q4 2025, an estimated $1.01M.
  • Monimus Capital Management first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
  • Monimus Capital Management's 89bio position peaked at $1.01M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Monimus Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.